Literature DB >> 34389882

A multi-dosing regimen to enhance the spatial memory of normal rats with α5-containing GABAA receptor negative allosteric modulator L-655,708.

Congcong Yuan1, An Gao1, Qiang Xu1, Beibei Zhang1, Rui Xue1, Yan Dou2, Chunshui Yu3,4.   

Abstract

RATIONALE AND
OBJECTIVES: The reported inconsistent effects of negative allosteric modulators of α5-containing GABAA receptors on learning and memory may be attributed to receptor selectivity, effective plasma concentration maintenance, and administration time. This study aimed to compare the effects of L-655,708 administered by single-dosing regimen versus multi-dosing regimen on spatial memory, signaling molecules, and brain functional connectivity.
METHODS: After comparing the maintenance time of the effective plasma concentration of L-655,708 between multi-dosing and single-dosing regimens, we further compared the effects of the administration of the two regimens at different phases (before-learning, during-learning, and before-probe) of the Morris water maze (MWM) test on the performance of learning and memory and the levels of signaling molecules related to learning and memory in hippocampal tissues. Functional connectivity analyses between hippocampal and cortical regions were performed to further clarify the effects of the multi-dosing regimen.
RESULTS: The multi-dosing regimen could maintain the effective plasma concentration of L-655,708 much longer than the single-dosing regimen. Only the multi-dosing regimen for L-655,708 administration during the learning period led to significant improvement in spatial memory in the MWM test and increases in levels of glutamate receptors and phosphorylated signaling molecules (p-PKAα, p-CaMKII, and p-CREB-1). Compared with the vehicle control, the multi-dosing regimen increased the functional connectivity of the left hippocampal CA1 with cingulate and motor cortices.
CONCLUSIONS: A multi-dosing regimen for L-655,708 administered during the learning period is an effective strategy to improve spatial memory, increase signaling molecule levels, and enhance the functional connectivity of the hippocampus.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Functional MRI; Hippocampus; Morris water maze; Negative allosteric modulators; Spatial memory; Western blot; α5-GABAAR

Mesh:

Substances:

Year:  2021        PMID: 34389882     DOI: 10.1007/s00213-021-05951-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  71 in total

Review 1.  Molecular mechanisms of memory acquisition, consolidation and retrieval.

Authors:  T Abel; K M Lattal
Journal:  Curr Opin Neurobiol       Date:  2001-04       Impact factor: 6.627

2.  L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors.

Authors:  John R Atack; Peter J Bayley; Guy R Seabrook; Keith A Wafford; Ruth M McKernan; Gerard R Dawson
Journal:  Neuropharmacology       Date:  2006-10-12       Impact factor: 5.250

3.  Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory.

Authors:  T Abel; P V Nguyen; M Barad; T A Deuel; E R Kandel; R Bourtchouladze
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

4.  Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors.

Authors:  John R Atack; Peter H Hutson; Neil Collinson; George Marshall; Graham Bentley; Christopher Moyes; Susan M Cook; Ian Collins; Keith Wafford; Ruth M McKernan; Gerard R Dawson
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

5.  Functional connectivity with the retrosplenial cortex predicts cognitive aging in rats.

Authors:  Jessica A Ash; Hanbing Lu; Lisa R Taxier; Jeffrey M Long; Yihong Yang; Elliot A Stein; Peter R Rapp
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-10       Impact factor: 11.205

6.  Rat pharmacokinetics and pharmacodynamics of a sustained release formulation of the GABAA alpha5-selective compound L-655,708.

Authors:  John R Atack; Andy Pike; Ashley Clarke; Susan M Cook; Bindi Sohal; Ruth M McKernan; Gerard R Dawson
Journal:  Drug Metab Dispos       Date:  2006-02-02       Impact factor: 3.922

Review 7.  Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA.

Authors:  John R Atack
Journal:  Pharmacol Ther       Date:  2009-09-19       Impact factor: 12.310

8.  In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist.

Authors:  John R Atack; Karen A Maubach; Keith A Wafford; Desmond O'Connor; A David Rodrigues; David C Evans; F David Tattersall; Mark S Chambers; Angus M MacLeod; Wai-Si Eng; Christine Ryan; Eric Hostetler; Sandra M Sanabria; Raymond E Gibson; Stephen Krause; H Donald Burns; Richard J Hargreaves; Nancy G B Agrawal; Ruth M McKernan; M Gail Murphy; Kevin Gingrich; Gerard R Dawson; Donald G Musson; Kevin J Petty
Journal:  J Pharmacol Exp Ther       Date:  2009-08-24       Impact factor: 4.030

9.  RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors.

Authors:  Theresa M Ballard; Frédéric Knoflach; Eric Prinssen; Edilio Borroni; Jeffrey A Vivian; Jennifer Basile; Rodolfo Gasser; Jean-Luc Moreau; Joseph G Wettstein; Bernd Buettelmann; Henner Knust; Andrew W Thomas; Gerhard Trube; Maria-Clemencia Hernandez
Journal:  Psychopharmacology (Berl)       Date:  2008-10-21       Impact factor: 4.530

10.  The SIGMA rat brain templates and atlases for multimodal MRI data analysis and visualization.

Authors:  D A Barrière; R Magalhães; A Novais; P Marques; E Selingue; F Geffroy; F Marques; J Cerqueira; J C Sousa; F Boumezbeur; M Bottlaender; T M Jay; A Cachia; N Sousa; S Mériaux
Journal:  Nat Commun       Date:  2019-12-13       Impact factor: 14.919

View more
  1 in total

1.  Hippocampal Inhibitory Synapsis Deficits Induced by α5-Containing GABAA Receptors Mediate Chronic Neuropathic Pain-Related Cognitive Impairment.

Authors:  Xuechun Cai; Lili Qiu; Chaoran Wang; Hang Yang; Zhenhui Zhou; Meng Mao; Yunqing Zhu; Yazhou Wen; Wenlan Cai; Wei Zhu; Jie Sun
Journal:  Mol Neurobiol       Date:  2022-07-18       Impact factor: 5.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.